Boothbay Fund Management’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-697
| Closed | -$89K | – | 1978 |
|
|
2022
Q3 | $89K | Sell |
697
-2,439
| -78% | -$311K | ﹤0.01% | 1780 |
|
|
2022
Q2 | $215K | Sell |
3,136
-1,217
| -28% | -$83.4K | 0.01% | 1451 |
|
|
2022
Q1 | $620K | Sell |
4,353
-64
| -1% | -$9.12K | 0.01% | 933 |
|
|
2021
Q4 | $736K | Buy |
4,417
+1,362
| +45% | +$227K | 0.02% | 748 |
|
|
2021
Q3 | $425K | Buy |
+3,055
| New | +$425K | 0.01% | 962 |
|
|
2021
Q2 | – | Sell |
-2,040
| Closed | -$840K | – | 1825 |
|
|
2021
Q1 | $840K | Buy |
+2,040
| New | +$840K | 0.03% | 555 |
|
|
2020
Q4 | – | Sell |
-762
| Closed | -$431K | – | 1197 |
|
|
2020
Q3 | $431K | Buy |
762
+182
| +31% | +$103K | 0.03% | 590 |
|
|
2020
Q2 | $55K | Buy |
+580
| New | +$55K | ﹤0.01% | 786 |
|